Biotech/Biopharma Analysts discuss SURMOUNT, a clinical trial for participants with Obstructive Sleep Apnea (OSA) on an Analyst/Industry conference call to be held on February 1.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LLY:
- LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer?
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- NC State Health Plan to stop paying for obesity drugs, NY Times reports
- Oppenheimer biotech/biopharma analysts hold analyst/industry conference call
- JPMorgan places ‘Positive Catalyst Watch’ on Inspire Medical
